Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
4.150
-0.210 (-4.82%)
At close: Feb 27, 2026, 4:00 PM EST
4.300
+0.150 (3.61%)
After-hours: Feb 27, 2026, 5:57 PM EST
Neuphoria Therapeutics Market Cap
Neuphoria Therapeutics has a market cap or net worth of $22.37 million as of February 27, 2026. Its market cap has increased by 196.69% in one year.
Market Cap
22.37M
Enterprise Value
235.27K
1-Year Change
196.69%
Ranking
Category
Stock Price
$4.15
Market Cap Chart
Since December 24, 2024, Neuphoria Therapeutics's market cap has increased from $10.79M to $22.37M, an increase of 107.36%. That is a compound annual growth rate of 85.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 22.37M | 7.23% |
| Dec 31, 2025 | 20.86M | 273.80% |
| Dec 31, 2024 | 5.58M | -48.27% |
| Dec 24, 2024 | 10.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IO Biotech | 25.48M |
| Reviva Pharmaceuticals Holdings | 25.39M |
| Cue Biopharma | 25.31M |
| Senti Biosciences | 25.04M |
| Skye Bioscience | 24.63M |
| Barinthus Biotherapeutics | 24.50M |
| Daré Bioscience | 24.29M |
| Exicure | 23.71M |